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vEXECUTIVE SUMMARY
Since 1999, the contraceptive prevalence rate (CPR) 
for modern methods in Nigeria has stalled at 8–10%. 
Maternal, neonatal and child health indices remain 
abysmally low with maternal and infant mortality 
ratios of 545/100,000 and 89/1,000 live births 
respectively. This is a result of multiple contribut-
ing factors such as lack of availability and access 
to long-acting contraceptive commodities, as well 
as a dearth of skilled service providers that can 
provide a wide range of methods to satisfy every 
woman’s needs. Currently, attention is being given 
to increased funding and commitment for family 
planning and reproductive health services, including 
the deployment of new technologies in developing 
countries, to mitigate the problem of unmet need 
for contraception and to improve maternal and child 
health. In line with this trend, the Council is conduct-
ing a three-year acceptability study of the progester-
one vaginal ring (PVR) in three sub-Saharan African 
Countries—Nigeria, Senegal, and Kenya. The Council 
research teams conducted assessments to map out 
the current family planning programs and contra-
ceptive technologies landscape to identify national 
priorities, evaluate stakeholder interest in the PVR, 
and devise appropriate pre-introductory activities. 
In Nigeria, the research team utilized three ap-
proaches to develop this country-specific report: 
review of available data; desk review of documents, 
project reports and policy guidelines; and key infor-
mant interviews. The interviews were held with govern-
ment officials, regulatory and development agencies, 
social marketing organizations, research institutions, 
advocacy groups, manufacturers and distributors, 
policymakers, and other members of the community. 
This report lays out Nigeria’s demographics and 
high fertility rates, describes the family planning 
program and policy context, and finally, reveals the 
stakeholder support thus far with a discussion on how 
best to proceed with introduction activities. 
This country mapping confirms the likelihood that 
the PVR would be well received in Nigeria and fill 
a large need in family planning. The PVR is a safe, 
long-acting, user-controlled product that can be eas-
ily inserted and removed by the woman herself with 
minimal coaching; this is especially appropriate for 
women in the North who frequent healthcare facilities 
sparingly due to an aversion to male healthcare pro-
viders, need for permission from male partners to visit 
health facilities, poverty, and a lack of skilled health 
personnel. The quick return to fertility after discontin-
uation of use makes the PVR a promising prospect for 
expanding contraceptive choice for women in Nigeria. 
All of these characteristics make the PVR a highly de-
sirable addition to the current contraceptive method 
mix in Nigeria. 
vi
1INTRODUCTION
While the progress made in recent decades in fertility 
reduction has been impressive, up to 222 million wom-
en in the developing world still report an unmet need 
for contraception (Singh and Darroch 2013). Part of the 
challenge in addressing current levels of unmet need is 
the limited use of contraception by women during the 
first six to 12 months postpartum and the discontinu-
ation rates, with about half of all users abandoning 
their methods six months after adoption. Both issues 
lead to limited success in effective birth spacing, which 
then impacts maternal and infant health. New methods 
are needed that offer greater ease of use, are women-
controlled, and do not require significant health infra-
structure or medical provider involvement for service 
delivery. One such method is the progesterone vaginal 
ring (PVR), a user-controlled, mid-acting contraceptive 
that, according to clinical trial data, is safe and effective 
for breastfeeding women. 
The Population Council has embarked on a three-
year project to explore the acceptability of the PVR 
among women, their partners, and providers in sub-Sa-
haran Africa and to develop a strategy for its introduc-
tion. From February to May 2012 assessments were 
undertaken in Kenya, Nigeria, and Senegal—potential 
countries for PVR introduction—to map the landscape 
of family planning programs and new contraceptive 
technologies to identify national priorities, and to as-
sess the level of interest in the product among stake-
holders and to design appropriate pre-introductory 
activities. The Council’s research teams in each of 
these countries employed three approaches to develop 
country-specific reports: a review of Demographic and 
Health Survey (DHS) data; a desk review of documents, 
project reports and policy guidelines; and key infor-
mant interviews. Interviews were held with represen-
tatives of government, regulatory, and development 
agencies; social marketing organizations; research 
institutions; manufacturers/distributors; the com-
munity; advocacy groups; public/private partnerships; 
other organizations providing family planning services; 
and policymakers. This report presents the findings 
from Nigeria and begins by describing the country 
demographic profile and unmet need for contraception. 
It then provides the family planning program and policy 
context, and concludes with the stakeholder support 
known thus far and a discussion for what this means 
moving forward. 
DEMOGRAPHIC PROFILE
Nigeria is the most populous country in Africa. With a 
population growth rate of 2.5%, the population is pro-
jected to reach 433 million by the year 2050, making it 
the third most populous country in the world, after India 
and China (Population Reference Bureau 2011). 
Although both maternal and infant mortality rates 
are very high (545/100,000 and 89/1,000 respec-
tively), contraceptive prevalence rate (CPR) for modern 
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2methods has not increased significantly since 1999; 
6.8% in 1999 and 9.7% presently (NPC and ICF Macro 
2009). This rate is not uniform across the country—in 
some parts of northern Nigeria, the contraceptive preva-
lence rate is as low as 2.5% (NPC and ICF Macro 2009).
CHILDBEARING AND  
CONTRACEPTIVE  
BEHAVIOR
Existing socio-cultural norms place a high value on fertil-
ity, encourage early marriage, limit women’s equality, 
place the power to decide who receives services in the 
hands of the provider, and support polygamy (Izugbara 
and Ezeh 2010; Caldwell and Caldwell 1987). Nigeria 
has a high fertility rate of 5.7, with some areas in the 
Northwest being higher. Studies have linked the North-
ern region’s high fertility to early marriage, of which it 
has one of the highest rates in the world; lack of infor-
mation about and access to family planning methods; 
men’s dominant roles as household decisionmakers; 
and polygyny. Polygyny encourages women to have more 
children than their co-wives to ensure that they will 
receive the largest share of the husband’s resources in 
the event anything should happen to him (Caldwell and 
Caldwell 1987). 
Compounding this need to have more children in 
order to secure greater economic and social status is 
the grave fear of infertility. A woman who can, or is ex-
pecting to reproduce again is regarded differently from 
a woman who cannot or does not want to. Even “behav-
ioral barrenness,” (Izugbara and Ezeh 2010) where one 
arranges or expresses the intention to no longer repro-
duce, has been looked down upon because of the way 
status is conferred upon families based on their number 
of children. As the Chairman of the Senate Committee 
on Health affirmed, “large family size ostensibly symbol-
izes and begets wealth, influence, respect, and fame”.3 
However, despite the traditional importance attached 
to fertility, many women do not support unregulated 
childbearing as they are aware of the physical risk asso-
ciated with high fertility and closely spaced births, and 
the social and economic consequences of large families 
(Caldwell and Caldwell 1987).
Unfortunately, there is a pervasive misconception in 
Nigeria that there are many negative health implications 
associated with the use of modern contraceptives. A 
qualitative study of Northern Nigerian women’s beliefs 
about modern contraceptives identified several nega-
tive implications of their use. Women expressed the 
belief that contraception causes mahaifan kulle [locked 
womb] and that extended use leads to a permanent 
loss of fertility—both serious consequences in a soci-
ety where fertility is so highly valued. They also voiced 
concerns that modern contraceptives are injurious to 
women’s health, possibly being laced with substances 
that cause cancer, result in birth defects, and lead to 
sexually transmitted infections (Caldwell and Caldwell 
1987). 
The country’s health infrastructure also plays a large 
role in maintaining the existing level of contraceptive 
use. Commodity shortages, weak logistics systems, and 
inadequate provider knowledge and skills impede the 
delivery of effective family planning services. Further-
more overall funding for the health sector is low; and un-
der health-sector reform, greater programmatic author-
ity has been transferred to lower levels that have limited 
capacity. These decentralized bodies do not have the 
required capabilities to plan, design, and implement 
effective services.
HEALTH SYSTEMS  
STRUCTURE
The national health system is organized into a three-
tiered service delivery system of primary, secondary, 
and tertiary levels, which are the responsibility of the 
local, state, and federal governments, respectively. Pri-
mary care is the entry point into the healthcare system; 
the secondary level focuses on general and specialist 
care; while the tertiary level covers teaching hospitals, 
federal medical centers, orthopedic hospitals, and 
psychiatric hospitals. The structure aims to serve the 
needs of the population but there are numerous lapses 
in practice. 
 Each state is required to have at least one tertiary 
care facility, but most people access their care through 
the most basic primary health care (PHC) facilities. 
Although up to 71% of Nigerians have access to a PHC 
facility located within 5 kilometers of their homes, many 
of these service delivery centers experience frequent 
supply stockouts, lack proper equipment and other es-
sential supplies, and have underqualified staff. 
Due to the limitations of public health care, private 
facilities can assure a certain standard of quality care. 
However, only 30% of Nigerians visit private facilities 
3for health care services. Despite this, the private sector 
in Nigeria provides upwards of 60% of family plan-
ning services, and is a dominant source for delivery of 
contraceptive (Tien et al. 2009); nonetheless, the public 
sector represents a large window of opportunity for scal-
ing up the delivery and distribution of this technology 
because of its capacity and proximity to more than 70% 
of Nigerians. 
FAMILY PLANNING AND  
REPRODUCTIVE HEALTH  
POLICY CONTEXT
In response to the recognition that a high population 
growth rate is detrimental to national development, the 
government of Nigeria approved the National Policy on 
Population for Development in 1988. A strong family 
planning program was called for as an integral compo-
nent of this policy. However, emerging issues such as 
HIV/AIDS, poverty, and gender mainstreaming programs 
detracted attention and funds away from the develop-
ment of a federal family planning program. Progress in 
the areas of family planning and reproductive health 
stagnated, so, in 2005, the government launched an 
updated version of this policy, termed the National 
Policy on Population for Sustainable Development. 
The goal of the 2004 Revised National Health Policy 
was to improve the quality of life and the standard 
of living for the population by reducing the national 
population growth rate; the total fertility rate; the infant, 
child and maternal mortality rates; and the prevalence 
of HIV/AIDS, while increasing the number of females 
enrolled in school and the literacy rate. 
The 2004 Revised National Health Policy outlines the 
various roles and responsibilities of the different levels 
of government and other organizations operating in the 
country to deliver or facilitate delivery of health services, 
including nongovernmental organizations. It also laid 
out programmatic strategies for ensuring a functional 
referral system through which people can access the 
appropriate care from primary, secondary, or tertiary 
facilities. The central government was to provide overall 
programmatic direction, and the state and local gov-
ernments were to work with the various health-related 
ministries and departments at state and local levels, 
development agencies, and other relevant institutions 
to adopt and implement these policies and programs. 
Investments in the family planning program have not 
increased, challenges remain with commodity security, 
and the existing method mix is considered limited. 
Contraceptive Use and Method Mix
Real and perceived barriers prevent many women from 
accessing health services, including family planning ser-
vices. The NDHS 2008 report showed that poverty was 
the main perceived barrier to accessing health services 
among women (56%), a 26 percentage point increase 
over the finding in the 2003 NDHS (30%). Other disen-
abling factors to access care include perceived lack of 
drugs, transport, and distance to the health facilities 
(33%), preference for a female provider (20%), and 
obtaining permission to visit healthcare facilities (10%) 
(NPC and ICF Macro 2009). While social and gender 
norms play a role in which populations utilize reproduc-
tive health and family planning services, income level 
does as well. Married women in the richest quintile are 
more likely to use a modern contraceptive (21%) than 
those in the poorest quintile (4%) (Caldwell and Caldwell 
1987). This statistic highlights just one of the many 
barriers that keep women in Nigeria from utilizing what 
reproductive health and family planning services, if any, 
may be available to them. Consequently, and as can be 
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4seen in Figure 2 below, only 15% of women of reproduc-
tive age use any method of contraception, 10% are us-
ing modern methods and 85% are not using any method 
at all (NPC and Macro ICF 2009). 
Modern contraceptives available in the program 
include barrier methods (male and female condoms), 
IUCDs, combined oral contraceptive pills (Exluton and 
Microgynon), injectables (Depo Provera and Noristerat), 
implants (Implanon and Jadelle), and female steriliza-
tion, while traditional or natural methods include the 
lactational amenorrhea method (LAM), rhythm method, 
withdrawal method, and folk method. 
According to the Nigeria Demographic and Health 
Survey (2008), 3% of married women use injectables 
and 2% use pills, male condom, and LAM each, while 
1% uses IUCDs. There appears to be a preference 
toward long- or mid-acting methods as can be inferred 
from the higher use of injectables (although only 3%). 
Preference for one contraceptive over another varies 
across the country. Married women in the South pre-
fer IUCDs, whereas their northern counterparts prefer 
injectables. IUCD insertion and removal require a more 
sophisticated health infrastructure in terms of equip-
ment and skilled providers, which are available more 
in the south. On the other hand, there is a dearth of 
skilled personnel in the north, and this, combined with 
poor health-seeking behavior, implies that northern 
clients may be content with other methods such as oral 
pills and injectables, which can be obtained at a nearby 
patient medical store. Furthermore, due to the fact 
that IUCD insertion requires 
some level of intimate contact 
between the clients and pro-
viders, religious and cultural 
reasons in the predominantly 
Muslim north may play a role 
in the widespread aversion 
toward IUCDs. 
Anecdotal evidence sug-
gests that the male condom is 
commonly used by young un-
married people, not necessar-
ily as a contraceptive method, 
but as protection against STIs. 
It is not particularly favored in 
marital relationships because 
of the long-held belief that it 
reduces sexual satisfaction 
and a relatively high failure 
rate in typical use. Additionally, the female condom has 
not enjoyed much popularity among women beyond its 
introductory phase. The uptake of combined oral con-
traceptive pills for many women is limited. The delay in 
return of fertility following prolonged use of injectables 
makes them unappealing to women in need of child 
spacing, due to the anxiety over such delays. 
Women may overcome social, economic, and other 
barriers to reach a health facility but encounter addi-
tional provider and medical barriers upon reaching it. 
Due to the lack of skilled and trained service providers 
in IUCD and implant insertion and removal, especially at 
the lower-level facilities, these methods are often not of-
fered. Providers too have biases and preferences for cer-
tain methods. For example, providers have been known 
to be judgmental and reluctant to serve single men and 
women, especially youths. They reflect the cultural con-
text of widespread belief that the use of contraceptives 
encourages female promiscuity as it reduces the risk of 
consequences (unintended pregnancy).  
In addition, women in Northern Nigeria seeking mod-
ern contraceptives at clinics are often asked to come in 
with their husbands. As some women may wish to keep 
their family planning intentions to themselves and prefer 
covert contraceptive use, this practice prevents these 
women from accessing services (Caldwell and Caldwell 
1987).
From the foregoing discussion, it can be seen that 
the contraceptive environment in Nigeria is plagued by 
a myriad of obstacles ranging from inadequate provid-
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Female sterilization
Pill
IUD
Injectables
Implants
Male condom
Female condom
LAM
Rhythm
Withdrawal
Folk method
FIGuRE 2: CHART SHOWING METHODS MIX IN NIGERIA AS OF 2008
5ers’ skills to lack of adequate supply of all methods from 
which a prospective user can chose. Although the Popu-
lation Council, as part of the International Contraceptive 
Access (ICA) Foundation, has been in partnership with 
some service-providing nongovernmental organizations, 
such as Pathfinder International, Rotary International, 
Marie Stopes, and IPPF, to increase access to the 
Levonorgestrel intra-uterine system (LNG IUS)—a form 
of IUCD—in Nigeria (part of an effort to expand method 
mix), and while demand for LNG IUS is steadily rising, 
the gap that needs to be filled is still wide. We hope that, 
introducing the PVR into Nigeria’s program will contrib-
ute to alleviating this difficulty.  
Previous Experiences of Contraceptive 
Introduction in Nigeria
The subdermal implant, Jadelle, was the last contra-
ceptive method to appear in Nigeria’s family planning 
program. It was launched as an improved version of 
Norplant, which was introduced in 1985, and thus was 
not subject to a formal introductory process. The product 
was well received by policymakers, providers, and clients 
alike as it provided an additional long-acting nonco-
ital dependent option with only two rods as opposed 
to Norplant with six rods. However, issues related to 
Jadelle’s availability and affordability have impeded its 
widespread introduction. When Jadelle was introduced, 
it was freely distributed to stakeholders and clients, 
however, this was short lived. After the introductory 
phase, Nigerians could not afford the product at private 
market costs, which were around N1,000 (USD $6)—be-
yond the purchasing power of ordinary Nigerians. The 
product is not very prevalent in the current method mix. 
However, as of 7 April 2011, all contraceptive commodi-
ties are free in Nigeria provided that they are accessed 
at a public facility. To what extent this policy is affecting 
supply and demand of Jadelle is yet undetermined. How-
ever, in general, continuous availability of contraceptive 
commodities is still an issue in Nigeria. 
BREASTFEEDING POLICIES 
AND PRACTICES
Despite overwhelming evidence in favor of exclusive 
breastfeeding, only 13% of infants in Nigeria are exclu-
sively breastfed to the age of six months (Federal Min-
istry of Health, 2011). Although almost all infants were 
breastfed (97%), less than half of the infants (38%) were 
put to breast within one hour of delivery, and only 68% 
commenced breastfeeding within the first day (NPC and 
ICF Macro 2009). At the national level, the median dura-
tion of exclusive breastfeeding is less than one month 
across all zones, wealth quintiles, and mother’s educa-
tion levels, and the median duration of predominant 
breastfeeding (with the addition of water and juices) 
is just three months. Traditionally, Nigerian women 
continue to breastfeed for up to two years, but the dura-
tion of both exclusive and predominant breastfeeding 
is shortening. According to the Nigerian Demographic 
and Health Survey (2008), the proportion of exclusively 
breastfed infants less than six months of age fell from 
17% in 2003 to 13% in 2008. The median duration of 
breastfeeding is 18 months though slightly longer in 
rural areas (19 months) in comparison to urban areas 
(16 months). Almost all breastfeeding children less than 
6 months of age were breastfed at least six times in a 
24-hour period (NPC and ICF Macro 2009). Women in 
the highest wealth quintile had weaned their baby com-
pletely by the age of 14 months. The median duration of 
postpartum amenorrhea is 11 months, although shorter 
in urban (8 months) than in rural areas (13 months).By 
as early as 8 months, 77% of mothers have resumed 
sexual intercourse (NPC and ICF Macro 2009). The 
median duration of postpartum abstinence is also very 
short at about 4 months with wide regional variation, 5 
months in all southern regions, 2 months for the north 
east and north west and 7 months for north central 
region (NDHS, 2008). 
The use of milk formula and other replacements 
for breast milk is on the rise among some women and 
HIV-positive women who have stopped breastfeeding 
altogether as part of the Prevention of Mother-to-Child 
Transmission (PMTCT) strategy. A survey conducted in 
2008 revealed that only 7% of all breastfeeding children 
under the age of three consume infant formula (NPC 
and ICF Macro 2009), and a higher proportion (24%) 
receives other forms of milk, mainly cow and goat. The 
high price of milk formula, which ranges from $6 to $12 
per sachet, may be responsible for the low intake rates 
despite the rising need for such products. A majority of 
the population is likely unable to afford infant formula 
even when required, given that the proportion of the 
population living on less than $2 a day is 84% (Popula-
tion Reference Bureau 2010).
6SECURING CONTRACEPTIVE 
COMMODITIES AND  
GETTING THEM TO  
MARKET
Commodity Procurement Process 
Neither the Federal Ministry of Health (FMoH) nor its 
Department of Family Health is involved in direct family 
planning commodities procurement; all family planning 
commodities come from donors. Procurement of repro-
ductive health and family planning commodities has 
historically never been included in the national budget. 
A policy breakthrough was achieved in FY2012 when FP 
commodities where included in the budget for the first 
time. It remains to be seen if this addition to the budget 
will result in improvements in family planning perfor-
mance indicators. Many states also do not have funds 
dedicated to family planning and reproductive health. 
The system relies entirely on donations from the United 
Nations Population Fund (UNFPA) for public-sector fam-
ily planning commodities; while the UK Department for 
International Development (DfID) and the United States 
Agency for International Development (USAID) provide 
private-sector support (Tien et al. 2009). 
The Contraceptive Logistic Management Section 
(CLMS) of the FMoH works closely with UNFPA to man-
age, track, and distribute contraceptive commodities. 
Other nongovernmental organizations, such as Planned 
Parenthood Federation of Nigeria (PPFN) and the As-
sociation for Reproductive and Family Health (ARFH), 
also access and purchase public-sector contraceptives 
through direct request to the central level. The Requi-
sition Issue Forms (RIFs) and Requisition, Issue, and 
Report Forms (RIRFs) serve as proxy mechanisms to 
determine the amount of supplies needed using estab-
lished maximum and minimum guidelines. The country 
commodity manager monitors the pipeline and issues 
trends annually; information that is tracked centrally. 
States, local governments, and service delivery points 
order their own commodities.
Independent of which commodity is procured; 
distribution is done from the center to the periphery: 
state governments, local governments, and then service 
delivery points. While local governments order quarterly, 
the service delivery points do so every two months. 
However, this ordering and distribution pathway is not 
seamless. All government levels fail to budget for con-
traception, so even donated commodities may not be 
transported to the needed points due to lack of funds to 
cover transportation costs. In 2002, the CLMS adopted 
the “Strategic Pathway to Reproductive Health Com-
modity Security” (SPARHCS) framework, a cost-recovery 
system to secure essential commodities for family plan-
ning and reproductive health programs. Unfortunately, 
issues with policy, financing, coordination, logistics, de-
mand creation, and service delivery have prevented this 
SPARHCS from effecting any change, and challenges 
remain in ensuring a consistent supply of commodities. 
Due to low demand for family planning services, money 
recovered from sale is not enough to maintain the 
system; transportation costs are covered solely by the 
cost-recovery system and not by any government source. 
Thus, it is common to experience nationwide commodity 
stock-out despite adequate stock at the central contra-
ceptive warehouse.
Product Registration
In Nigeria, only the manufacturer can register a product, 
but a waiver can be obtained. The Standard Operating 
Procedures (SOPs) ensure that contraceptives meet 
quality standards while the National Agency for Foods, 
Drugs Administration, and Control (NAFDAC) is the 
statutory body responsible for monitoring the quality 
of contraceptives imported into the country. Under its 
pharmaco-vigilence initiative, the NAFDAC is responsible 
for updating the safety profile of all drugs and medicine. 
If research needs to be conducted, the National Institute 
for Medical Research (NIMR) must approve and monitor 
the research. Once a product is cleared, the FMoH (and 
thus the federal government) accept the product for its 
intended use. 
SUPPORT FOR THE PVR 
Perception of PVR
The stakeholders consulted indicated that introduc-
tion of the PVR is likely to be acceptable to Nigerian 
society and fills a large gap in unmet family planning 
need. Research and input from medical professionals, 
politicians, senior government officials, religious and 
traditional leaders, and international and local non-
governmental organizations show that there is a need 
for a contraceptive that requires little training on the 
part of the provider; does not require a sophisticated 
health infrastructure; is very safe and long-acting and 
7thus does not require monthly visits to a health cen-
ter; is user-friendly and woman-controlled; and sees a 
quick return of fertility following discontinuation of the 
method. The PVR addresses all of these concerns and 
discussions with stakeholders indicate that it would be 
a welcome addition to the existing mix of contraceptive 
methods. 
Policymakers and stakeholders in Nigeria perceive 
the vaginal ring innovation as a potential product to fill 
the contraceptive gap, especially for women in north-
ern Nigeria, in the immediate postpartum period. Thus 
many stakeholders believe that the progesterone vaginal 
ring would be highly favored by northern clients as it is 
user-friendly, long-acting, does not require sophisticated 
health infrastructure, has a high safety profile, requires 
minimal facility visits, and fertility returns immediately 
after discontinuation of use. 
In general, stakeholders in Nigeria welcome the 
vaginal ring and describe it as a major breakthrough in 
expanding contraceptive method choice. It would further 
empower women in the southern region to take control 
of their reproductive health. Moreover, it would be espe-
cially appropriate and suitable for women in the North 
who access healthcare facilities much less frequently, 
due to an aversion toward male healthcare providers, 
frequent need for permission from male partners to visit 
health facilities, poverty, and a lack of skilled personnel.
Stakeholders did express some uncertainty that the 
ring might make intercourse uncomfortable, which could 
affect its popularity. However explanation, demonstra-
tion, and the testimony of satisfied clients assuaged 
these concerns. 
Historically there have been religious-based antago-
nists of family planning methods in the country. They 
may be opposed to the PVR simply because it is a mod-
ern form of contraception. To date, no group has voiced 
any opposition to the PVR.
The main lesson to take away from the example of 
Jadelle is cost-appropriateness. At present, all family 
planning commodities are free in Nigeria provided that 
they are accessed at public facilities, but when Jadelle 
was first introduced they were not. Initially, when Jadelle 
was distributed to stakeholders and clients, it was highly 
popular. However, there was no arrangement in place 
to ensure its continuous availability at a subsidized and 
affordable price. Ordinary Nigerians could not afford 
it at private market price, thus, the initial enthusiasm 
abated. This experience must be considered as the PVR 
is being introduced in Nigeria. The design of the PVR is 
likely going to mitigate part of this problem. Developing a 
strategic plan for eventual introduction of the product is 
an appropriate approach.
Required Resources
Stakeholder interviews revealed key resources that were 
recommended to ensure successful future introduction 
of the PVR:
1. Competent team members
2. Local advocates
3. Good product image
4. Timely feedback
5. Local experts
The PVR would be a welcomed 
method as it reduces facility  
visits, is user-controlled, can be 
inserted and removed by women 
themselves, and requires minimal 
counseling and instruction on 
proper use. It would also further 
empower women in the southern 
region to take charge of their 
reproductive lives. 
	  
Stakeholders have deemed 
the PVR to be highly 
acceptable within the context 
of the country’s family 
planning services because the 
product delivers progesterone, 
a hormone already available in 
various forms in Nigeria. 
	  
8DISCUSSION
Over the past decade in Nigeria, both the contraceptive 
prevalence rate and the high unmet need for contracep-
tion have remained fairly static. Likewise, maternal and 
infant mortality rates and other reproductive health indi-
ces have not changed significantly. As stated elsewhere, 
multiple reinforcing factors are at fault, both individually 
and in concert. Lack of availability and access to long-
acting contraceptives, lack of skilled providers to provide 
implants and IUCDs, fragile health infrastructure, and 
limited options for postpartum family planning are promi-
nent among the numerous obstacles to widespread use 
of family planning in Nigeria.
This rapid assessment of the contraceptive land-
scape in Nigeria has brought to light the huge demand 
for further expanding the contraceptive method mix, 
and specifically, the key role that PVR would play in this 
respect. For example, married women in Nigeria pre-
fer progestogens injectables (either Depo Provera or 
Noristerat). These require multiple facility visits and the 
presence of skilled providers for administration. Some 
of these providers are male with whom contact is not 
favored by women in northern Nigeria for cultural and re-
ligious reasons. The PVR can be inserted by the woman 
herself with minimal coaching, obviating the need for 
frequent visits to health facilities, skilled service provid-
ers, and contact with male providers. The use of other 
postpartum family planning methods, such as Norplant 
and IUCDs, is also a challenge due to a lack of skilled 
providers. All these factors highlight the programmatic 
gaps that the PVR can potentially fill.
For the PVR to be fully efficacious for contraception, 
good breastfeeding practice is mandatory. Specifically, 
four breastfeeding episodes are required. Given the 
breastfeeding culture in Nigeria where almost all infants 
are breastfed (97%), the PVR has found a friendly envi-
ronment. Since only 13% of breastfeeding women exclu-
sively breastfeed by six months, the LAM method will not 
suffice and effective supplementation is highly desirable, 
and the PVR fulfills these needs. Although eligibility can-
not translate to acceptability, experience with the PVR 
so far has demonstrated a high level of acceptability in 
environments where it is intensely studied such as nu-
merous countries in Latin America, Egypt, and India. 
One global discussion that bears mentioning is the 
relationship between hormonal contraceptives and the 
risk of HIV transmission. However, such concerns were 
only expressed in research settings and academia, and 
not yet at the population and policy levels. The recent 
declaration by the World Health Organization advisory 
committee dispels this concern and recommends con-
tinuous use of hormonal methods in all client subgroups. 
It is worth noting that prior research has indicated an 
increased prevalence of vaginal infection among post-
partum women in Nigeria. This acceptability study will 
carefully select women with vaginal infection for further 
management before enrollment.
One challenge that must be considered is the cost 
of this ring when it is finally introduced into the Nigerian 
market. Currently, the Nigerian government policy on 
family planning offers all contraceptives at public facili-
ties free of charge provided they are available. Therefore, 
for the PVR to compete favorably, the unit cost must be 
competitive. This is one of the reasons why the federal 
government of Nigeria, through the Federal Ministry of 
Health, has been engaged in this effort from the outset. 
91. Director, Department of Family Health, Federal 
Ministry of Health, Federal Secretariat Complex, 
Abuja
2. Director, Hospital Services Department, Federal 
Secretariat, Federal Secretariat Complex, Abuja 
3. The Chairman, Senate Committee on Health, 
National Assembly Complex, Abuja, Nigeria
4. Director, Center for Reproductive Health and 
Population, University College Hospital, Ibadan
5. Director General, National Agency for Foods, 
Drugs Administration, and Control, Abuja, Nigeria
6. Director General, Nigerian Institute for Medical 
Research, Yaba, Lagos, Nigeria
7. Director of Research and Statistics, National 
Population Commission of Nigeria, Abuja
8. Head, Maternal and Child Health, USAID, Murja-
natu House, Abuja, Nigeria
9. The Nigerian Urban Reproductive Health Initiative, 
St. James’ House, Wuse, Abuja
10. The President/CEO, Association of Reproductive 
and Family Health, Millennium Builders’ Plaza, 
Central Business District, Abuja
11. Advocacy Nigeria/Family Planning Action Group, 
Lobito Crescent, Wuse 11, Abuja
12. Executive Director, Women’s Health and Action 
Research Center, Benin City, Nigeria
13. Registrar/CEO, Pharmacists Council of Nigeria, 
Idu Industrial Area, Garki, Abuja
14. The Registrar, Nursing and Midwifery Council of 
Nigeria, Abuja
15. Executive Director, Development Communication 
Network, Surulere, Lagos
16. Executive Director, Center for Communication 
Programs—Nigeria, Maitama, Abuja
17. Federation of Muslim Women’s Association of 
Nigeria, Maitama, Abuja
18. The President, Association of Community Pharma-
cist Practitioners, Abuja, Nigeria
19. Department of Obstetrics and Gynecology, Univer-
sity College Hospital, Ibadan
20. Medical Director, Wuse General Hospital, Abuja
21. Society for Family Health, Area 11, Garki, Abuja
22. Gender and Development Specialist, United Na-
tion Children’s Fund, UN House, Abuja
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